CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
11 hedge funds and large institutions have $2.58M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$775K | |
| 2 | +$233K | |
| 3 | +$220K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$158K |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$15K |
Top Sellers
| 1 | -$978K | |
| 2 | -$693K | |
| 3 | -$6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.41K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$667 |